Addex Therapeutics Ltd(ADXN)

POST7.640.04+0.53%16:00 EDT

7.60-0.06-0.78%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
  Reuters · 06:03
  Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
- Addex to Present at the 2025 Swiss Equities Baader Conference
  GlobeNewswire · 01-08
  Addex to Present at the 2025 Swiss Equities Baader Conference
- Top Premarket Decliners
  MT Newswires Live · 2024-12-27
  Top Premarket Decliners
- Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
  Zacks · 2024-11-27
  Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
- Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...
  GuruFocus.com · 2024-11-23
  Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...
- Addex Therapeutics GAAP EPS of -CHF0.02, revenue of CHF0.06M
  seekingalpha · 2024-11-22
  Addex Therapeutics GAAP EPS of -CHF0.02, revenue of CHF0.06M
- Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M
  Benzinga · 2024-11-22
  Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M
- Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
  Reuters · 2024-11-20
  Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
- Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?
  Zacks · 2024-11-11
  Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?
- Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
  GlobeNewswire · 2024-11-11
  Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
- Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
  Reuters · 2024-11-08
  Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview
- Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
  Zacks · 2024-10-25
  Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
- Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...
  GuruFocus.com · 2024-10-01
  Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...
- Addex Therapeutics Reported Q2 EPS Of CHF0.08, Cash Balance Of CHF3.8M
  Benzinga · 2024-09-30
  Addex Therapeutics Reported Q2 EPS Of CHF0.08, Cash Balance Of CHF3.8M
- Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
  GlobeNewswire · 2024-09-30
  Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
Company Profile
Company Name
Addex Therapeutics Ltd
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.addextherapeutics.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
- 2024-08-14
  Beneficial Ownership Change
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-08-05
  Beneficial Ownership Change
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 2024-04-18
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2023-12-08
  Beneficial Ownership Change
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-11-29
  Beneficial Ownership Change
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 2023-06-08
  Employee Stock Ownership
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2023-05-31
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-05-31
  [Amend]Public Prospectus
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2023-05-11
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-05-10
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-05-10
  [Amend]Public Prospectus
  F-1/A [Amend] - Registration statement for certain foreign private issuers
  F-1/A [Amend] - Registration statement for certain foreign private issuers
- 2023-05-02
  Public Prospectus
  F-1 - Registration statement for certain foreign private issuers
  F-1 - Registration statement for certain foreign private issuers
- 2023-04-09
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2023-04-04
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2023-03-30
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership

1D
5D
Day
Week
Month

Loading ...

High

7.93

Open

7.88

Volume%

0.30

Low

7.54

7.66

T/O Rate

0.72%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

Addex Therapeutics Ltd(ADXN)

Company Profile